Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy A case report

被引:1
作者
Shen, Yingjing [1 ]
Xu, Chenggang [1 ]
机构
[1] Second Mil Med Univ, Affiliated Hosp 3, Dept Nephrol, Shanghai, Peoples R China
关键词
acute kidney injury; acute respiratory distress syndrome; hypertrophic cardiomyopathy; polycystic kidney disease; proteinuria; TASK-FORCE; PROGRESSION; POPULATION; GUIDELINES; DIAGNOSIS; DEATH;
D O I
10.1097/MD.0000000000008625
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: This report describes the novel sampling of autosomal dominant polycystic kidney disease (ADPKD) combined with hypertrophic cardiomyopathy (HCM). Symptoms and clinical findings: A 48-year-old Chinese man presented with anasarca, hypourocrinia, gross hematuria, and weight gain by 10kg subsequently developed acute kidney injury after struck by acute respiratory distress syndrome, really a threat to his heart. Diagnoses: Abdominal ultrasound revealed multiple small cysts in both kidneys, with the right kidney measuring 11.6cm in length, and the left kidney measuring 11.5cm in length, which supported ADPKD. Echocardiography showed left ventricular posterior wall thickness measuring 15.2mm, interventricular septum measuring 17.2mm, left atrial size 31.9mm, ejection fraction measuring 69%, approving the diagnose of HCM. Therapeutics interventions: Because of the failure treatment with tripterygium wilfordii and valsartan, the patient was administered with prednisone 1mg/kg/day. Continuous renal replacement therapy was required to prevent heart and kidney from failure. Outcomes: The patient responded well and his renal function improved. Conclusion: This is the first reported case of ADPKD with HCM, with complete remission of acute kidney injury and preservation of cardiac function. Serial checks and measures should be considered for appropriate treatment of ADPKD patient who present with rapid decline of renal function. We present detailed analysis of the patient's disease course and review literature. Written informed consent was obtained from the patient for publication of this case report. It has been permitted by Committee on Ethics of Biomedicine, Second Military Medical University.
引用
收藏
页数:3
相关论文
共 21 条
  • [1] Ahmed ER, 2006, SAUDI J KIDNEY DIS T, V17, P511
  • [2] ALVARES R, 1982, BRIT HEART J, V48, P204
  • [3] Brosnahan GM, 2006, NEW ENGL J MED, V355, P733
  • [4] Autosomal dominant polycystic kidney disease with diffuse proliferative glomerulonephritis - An unusual association: A case report and review of the literature
    D'Cruz S.
    Singh R.
    Mohan H.
    Kaur R.
    Minz R.W.
    Kapoor V.
    Sachdev A.
    [J]. Journal of Medical Case Reports, 4 (1)
  • [5] DAVIES F, 1991, Q J MED, V79, P477
  • [6] Hypertrophic cardiomyopathy - Do we have the algorithm for life and death?
    Doevendans, PA
    [J]. CIRCULATION, 2000, 101 (11) : 1224 - 1226
  • [7] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
    Elliott, Perry M.
    Anastasakis, Aris
    Borger, Michael A.
    Borggrefe, Martin
    Cecchi, Franco
    Charron, Philippe
    Hagege, Albert Alain
    Lafont, Antoine
    Limongelli, Giuseppe
    Mahrholdt, Heiko
    McKenna, William J.
    Mogensen, Jens
    Nihoyannopoulos, Petros
    Nistri, Stefano
    Pieper, Petronella G.
    Pieske, Burkert
    Rapezzi, Claudio
    Rutten, Frans H.
    Tillmanns, Christoph
    Watkins, Hugh
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (39) : 2733 - +
  • [8] FACTORS AFFECTING THE PROGRESSION OF RENAL-DISEASE IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    GABOW, PA
    JOHNSON, AM
    KAEHNY, WD
    KIMBERLING, WJ
    LEZOTTE, DC
    DULEY, IT
    JONES, RH
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (05) : 1311 - 1319
  • [9] 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    Gersh, Bernard J.
    Maron, Barry J.
    Bonow, Robert O.
    Dearani, Joseph A.
    Fifer, Michael A.
    Link, Mark S.
    Naidu, Srihari S.
    Nishimura, Rick A.
    Ommen, Steve R.
    Rakowski, Harry
    Seidman, Christine E.
    Towbin, Jeffrey A.
    Udelson, James E.
    Yancy, Clyde W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) : E212 - E260
  • [10] Nephrotic syndrome and IgA nephropathy in polycystic kidney disease
    Hiura T.
    Yamazaki H.
    Saeki T.
    Kawabe S.
    Ueno M.
    Nishi S.
    Miyamura S.
    Gejyo F.
    [J]. Clinical and Experimental Nephrology, 2006, 10 (2) : 136 - 139